• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Genetic, clinical, lifestyle and sociodemographic risk factors for head and neck cancer:

byPaary BalakumarandAlex Chan
April 13, 2025
in Cardiology, Chronic Disease, Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The highest-ranking phenotypic predictors of head and neck cancer included past tobacco smoking, job code at baseline, pain experienced during the last month, qualifications, FVC (Z score), and blood pressure.

2. Single nucleotide polymorphisms were less important in predicting the risk of head and neck cancer than phenotypic variables. 

Evidence Rating Level: 2 (Good) 

Head and neck cancer (HNC) refers to malignant tumors in the nasal cavity, oral cavity, pharynx, and larynx and accounts for over 300,000 deaths worldwide. 50-75% of these cases are diagnosed at the “advanced” stage, creating the need for risk prediction models. This retrospective biobank study looked at 502,367 participants from the UK Biobank between 2006 and 2021 to identify the relative importance of known risk factors and to identify novel risk factors. Data on potential risk factor exposure was collected through questionnaires/interviews, phenotype screening, and genetic testing. At baseline, men were more likely to get HNC (p < 0.001). Additionally, HNC was associated with poor or fair overall health rating, lower BMI with lower body fat percentage, engaged in less physical activity, had long standing illness/disability, more medications taken, high blood pressure, greater hand grip strength, pain during the past month, lower household income, lower educational attainment, and used tobacco. Incident cases were more likely to drink alcohol, smoke, have wheezing in the chest, experience shortness of breath with walking, and consume processed meat 2-4 times/week. There is also a significant difference in single-nucleotide polymorphisms (SNPs) between HNC incident cases and controls (p < 0.001), including rs259919-G (ZNRD1ASP gene) SNPs being more common in HNC incidences whereas rs1131769-T (STING1 gene) and rs28419191-T (ECSCR – SMIM33 gene) SNPs were more prevalent in controls. The highest-ranking phenotypic predictors of head and neck cancer included past tobacco smoking, job code at baseline, pain experienced during the last month, qualifications, FVC (Z score), and blood pressure. Single nucleotide polymorphisms were less important in predicting risk of head and neck cancer than phenotypic variables as none of the studied 25 genes were in the top 50 predictors of HNC. 

Click to read the study in PLOSONE

Image: PD

RELATED REPORTS

Guideline-based lymph node sampling is not associated with increased postoperative complications in lung cancer

Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs

2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: cancerchronic diseasehead and heck canceroncologysmoking
Previous Post

Measuring metabolic energy expenditure for individuals with lower limb amputation

Next Post

2 Minute Medicine Rewind April 14, 2025

RelatedReports

Lessons from real-world implementation of lung cancer screening
Chronic Disease

Guideline-based lymph node sampling is not associated with increased postoperative complications in lung cancer

June 9, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Oncology

Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs

June 4, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma

2MM: Pharma Roundup – Pfizer’s $10.5B Innovent oncology partnership, Guselkumab (Tremfya) gains a broader psoriatic arthritis label, Venetoclax (Venclyxto) expands first-line CLL options, and Seladelpar (Livdelzi) advances in primary biliary cholangitis

June 3, 2026
Chronic Disease

Immunosuppression with systemic glucocorticoids close to initiation of immune checkpoint inhibitor is associated with worse survival outcomes

May 25, 2026
Next Post

2 Minute Medicine Rewind April 14, 2025

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Increased tirzepatide use for glycemic and weight control since United States market entry

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • TikTok’s cortisol face trend meets endocrine reality
  • Semaglutide (Ozempic) raises questions about mood and nonresponse
  • Cruise ship hantavirus outbreak turns into a global contact tracing test
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.